Qualigen Therapeutics Inc is a biotechnology company focused on the development and commercialization of novel therapeutic products for the treatment of cancer and infectious diseases using nanoparticle coating technology. Qualigen Therapeutics Inc is a biotechnology company focused on the development and commercialization of novel therapeutic products for the treatment of cancer and infectious diseases using nanoparticle coating technology.
Carlsbad, CA, Dec. 05, 2024 (GLOBE NEWSWIRE) -- Qualigen Therapeutics (NASDAQ: QLGN) (the “Company” or “Qualigen”) today announced that the Company received formal notice from The Nasdaq Stock...
New York, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Univest Securities, LLC (“Univest”), a member of FINRA and SIPC, and a full-service investment bank and securities broker-dealer firm based in New...
Carlsbad, CA, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ:QLGN) ("Qualigen" or the "Company"), Qualigen Therapeutics, Inc., is a life science company focused on...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.27 | -5.93406593407 | 4.55 | 4.67 | 3.9 | 21785 | 4.36210661 | CS |
4 | 0.43 | 11.1688311688 | 3.85 | 4.67 | 3.805 | 28325 | 4.26607451 | CS |
12 | -4.22 | -49.6470588235 | 8.5 | 10.45 | 3.3358 | 3051575 | 5.73617837 | CS |
26 | -13.415 | -75.8123763775 | 17.695 | 21.4 | 3.3358 | 1799122 | 7.82247647 | CS |
52 | -21.005 | -83.0729681629 | 25.285 | 29.435 | 3.3358 | 3977530 | 15.51992502 | CS |
156 | -495.72 | -99.144 | 500 | 760 | 3.3358 | 1506515 | 51.72766236 | CS |
260 | -3620.72 | -99.8819310345 | 3625 | 3950 | 3.3358 | 1789834 | 659.75299466 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約